ACUTE TREATMENT OF MIGRAINE
Clinical trials for ACUTE TREATMENT OF MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new ACUTE TREATMENT OF MIGRAINE trials appear
Sign up with your email to follow new studies for ACUTE TREATMENT OF MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer tests migraine relief safety in kids as young as 6
Symptom relief Recruiting nowThis study aims to check the long-term safety of a migraine medicine called rimegepant in children and teenagers aged 6 to 18. Researchers will enroll 600 participants who experience migraines to monitor for side effects over time. The focus is on understanding how well young peo…
Matched conditions: ACUTE TREATMENT OF MIGRAINE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
First look: pfizer tests new migraine spray for kids
Symptom relief Recruiting nowThis early-stage study is testing the safety and how children's bodies process Zavegepant, a nasal spray medicine for migraine attacks. The trial includes 16 children aged 6-12 who have experienced migraines for at least 6 months. Researchers will give each child a single dose an…
Matched conditions: ACUTE TREATMENT OF MIGRAINE
Phase: PHASE1 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Mar 30, 2026 14:27 UTC